In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bristol consolidating discovery research on East Coast, closing Seattle site.

Executive Summary

BRISTOL CONSOLIDATES DISCOVERY RESEARCH ON EAST COAST with the closing of its Seattle discovery research operation. Half of the 240 staff members at the Seattle immunology discovery operation will be invited to relocate to Princeton, N.J., Bristol-Myers Squibb announced April 23. The transition is expected to be completed by early 1998. The Seattle site was formerly the home of Oncogen, a joint venture of Syntex and Genetic Systems; Bristol became sole owner of the site in 1986 following its purchase of Genetic Systems.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts